Project iFIT PPI-Inhibitors – PPI inhibitors targeting the Replication protein A (RPA) as a promising new therapy option…

Basic data

Acronym:
iFIT PPI-Inhibitors
Title:
PPI inhibitors targeting the Replication protein A (RPA) as a promising new therapy option against resistant solid tumors
Duration:
01/09/2019 to 31/10/2020
Abstract / short description:
PPI inhibitors targeting the Replication protein A (RPA) as a promising new therapy option against resistant solid tumors

Involved staff

Managers

Faculty of Science
University of Tübingen
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Other staff

Department of Pharmacy and Biochemistry
Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry
Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Local organizational units

Pharmaceutical Institute
Department of Pharmacy and Biochemistry
Faculty of Science

Funders

Bonn, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.